W. Douglas Figg, Sr., Pharm.D., Medical Oncology Branch
A Promising New Cancer Target: The HIF-1/p300 Interaction and Lead Compounds
Shyam K. Sharan, Ph.D., Mouse Cancer Genetics Program
Identification of Genes Involved in BRCA1 and BRCA2-Mediated Tumorigenesis Using Mouse ES Cells
Katherine E. Warren, M.D., Pediatric Oncology Branch
Differential Gene Expression and Targeting of Gliomas Using Low Dose, Decelerated Radiation
Yun-Xing Wang, Ph.D., Structural Biophysics Laboratory
Determining Three-Dimensional Solution Structures of Large RNAs
Samuel F. Bunting, Ph.D., Experimental Immunology Branch
Mapping Chromosome Breaks in B Lymphocytes Using ChIP-Seq
Orla M. Casey, Ph.D., Cell and Cancer Biology Branch
Generation and Characterization of a Transgenic Mouse for the Prostate Cancer Fusion Protein TMPRSS2-ERG
Yoshimi Endo, M.D., Ph.D., Laboratory of Cellular and Molecular Biology
Analysis of Wnt Antagonist Gene Methylation in Circulating DNA as a Biomarker for Renal Cell Cancer
Theresa M, Geiman, Ph.D., Laboratory of Cancer Prevention
Isolation and Characterization of Cancer Stem Cells Using a Tagged ES Cell Gene Marker
Jordan D. Irvin, Ph.D., Gene Regulation and Chromosome Biology Laboratory
Study of Transcriptional Fidelity In Vivo
Michal Legiewicz, Ph.D., Retroviral Replication Laboratory, HIV Drug Resistance Program
Arti N. Santhanam, Ph.D., Laboratory of Cancer Prevention
Structural Determinants at 5′ UTR of Cancer Relevant mRNAs Regulated at the Level of Translation
Amy E. McKee, M.D., Pediatric Oncology Branch
Neuroblastoma: Every Cell Is a Tumor-Initiating Cell
Gianluca Pegoraro, Ph.D., Laboratory of Receptor Biology and Gene Expression
A Functional Screen for the Discovery of Novel Protein Quality Control Factors in Mammalian Cells
Ashutosh Rao, Ph.D., CCR Office of the Director
A Mitochondrially Targeted Redox Agent for Enhanced Tumor Killing and Cardioprotection from Doxorubicin
Joseph Riss, Ph.D., Laboratory of Cancer Biology and Genetics
Cancer as Wounds That Do Not Heal: In-Vitro and In-Vivo Testing of RCC Combinational Drug Therapy
Krisada Sakchaisri, Ph.D., Laboratory of Protein Dynamics and Signaling
A Novel Method (PCAT) for Selective Purification of Dimeric DNA-Binding Proteins
Misako Sato, Ph.D., Laboratory of Cancer Biology and Genetics
High Throughput Screening for Drugs that Restore Tumor Suppressor Responses to TGF-beta in Cancer
Yih-Horng Shiao, Ph.D., Laboratory of Comparative Carcinogenesis
Pyrosequencing with Terminator Chemistry for Allele-Specific Haplotyping and DNA Methylation
Diana A. Stavreva, Ph.D., Laboratory of Receptor Biology and Gene Expression
Real Time Interactions of the p53 Tumor Suppressor with Its Regulatory Elements in Living Cells
Christine Tomlinson, Ph.D., Laboratory of Cancer Biology and Genetics
Generation, Characterization and Oncogenic Manipulation of Mammary Progenitor Cells from ES Cells
Shinji E. Tsutsumi, M.D., Urologic Oncology Branch
Molecular Determinants for Extracellular Secretion of Heat Shock Protein 90